From Sarah Haywood, MedCity’s CEO
From the very start of MedCity’s life, we have been absolutely clear that our focus must include the growth of medical and digital technologies as well as traditional biotech. That was reinforced back in autumn 2014 when Lord Darzi’s Better Health for London report proposed that London should make the most of its life sciences and tech strengths to lead the way in digital health commercialisation and adoption. So I’m really pleased that this week we have launched DigitalHealth.London and its associated Digital Health Accelerator, a project led by London’s three Academic Health Science Networks in partnership with MedCity to speed up the use of digital technologies and grow the digital health economy. More details on the initiative and on our first event for companies taking place in March are below.
Finally, a quick thank you to all those who joined us for last month’s Future of Healthcare Investor Forum – the second time we have held the event with the London Stock Exchange, with 2017’s event already in planning. I think everyone came out buoyed by the confidence and dynamism of UK life sciences, which was tangible throughout. You can read Sarah Haywood’s reflections on the event below.